Sector:
Biotech
Life Science
About
Callio Therapeutics is focused on developing multi-payload antibody-drug conjugates to transform cancer patient outcomes. The company is providing new multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies that enable targeted delivery of multi agents to tumor cells to optimize therapeutic benefit. Its lead program is a HER2-targeted dual-payload ADC.
YouTube
Team
